Skip to main content
Premium Trial:

Request an Annual Quote

Going GMO (as Quietly as Possible)

An article from yesterday's New York Times details the coming challenges in deriving food from genetically modified organisms, particularly here in the US, where so far there aren't a lot of guidelines on the subject. Getting FDA to "spell out the rules of the game," the article says, could be the encouragement investors need to get active in this area -- while others contend that such guidelines would scare the public by having the GMO term associated with this food.

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.